Psycho-oncology: a brief history and case study

J Okla State Med Assoc. 2013 Dec;106(12):471-4.

Abstract

Ms. W. is a 55-year-old retired Caucasian woman who was diagnosed with esophageal cancer in October 2011. She underwent neoadjuvant chemotherapy with subsequent esophagectomy. She sought psychiatric help after receiving her cancer diagnosis. The field of psycho-oncology was developed to assist cancer patients and caregivers through their "cancer journey" from the time of diagnosis, throughout treatment and beyond. Criteria-defined psychiatric disorder, with adjustment disorder being the most common, is reported in approximately 33% to 50% of cancer patients. These realities have given psychiatry a role in the multi-disciplinary care approach in major cancer centers around the country. In this article, we describe the challenges faced by Ms. W. during her cancer diagnosis and provide a review of the literature in the emerging field of psycho-oncology and its role in the multidisciplinary care of cancer patients.

Publication types

  • Case Reports

MeSH terms

  • Antidepressive Agents, Second-Generation / therapeutic use
  • Carcinoma, Squamous Cell / complications*
  • Carcinoma, Squamous Cell / psychology*
  • Carcinoma, Squamous Cell / therapy
  • Citalopram / therapeutic use
  • Clonazepam / therapeutic use
  • Depressive Disorder / complications*
  • Depressive Disorder / drug therapy
  • Depressive Disorder / psychology*
  • Esophageal Neoplasms / complications*
  • Esophageal Neoplasms / psychology*
  • Esophageal Neoplasms / therapy
  • Esophagectomy / methods
  • Esophagectomy / psychology
  • Female
  • GABA Modulators / therapeutic use
  • Humans
  • Middle Aged
  • Neoadjuvant Therapy / methods
  • Neoadjuvant Therapy / psychology

Substances

  • Antidepressive Agents, Second-Generation
  • GABA Modulators
  • Citalopram
  • Clonazepam